Highlights
- In July the company reported a AUD 3.4 million engineering contract from Remedy Robotics for surgical robotics work.
- During the year the company raised AUD 5.22 million before costs through an entitlement offer at AUD 0.005 a share.
- Loan facilities of AUD 6 million are fully drawn, unsecured and charged at 10% to 12% interest.
- Hydrix has also said it is reviewing 12 defence technology opportunities, four of them actively.
Hydrix Limited (ASX:HYD) is an engineering services company whose most recent quarter brought higher services Revenue and early progress in a defence counter-drone project, while its Balance Sheet still carries negative net Assets and AUD 6 million of fully drawn loans. The key near-term event is the Annual General Meeting on 26 November 2026, where shareholders will vote on converting loans from related parties into equity.
What Hydrix does
Melbourne-based Hydrix designs and engineers products, largely medical and industrial devices, for other companies. According to its FY26 reports it runs four segments: Hydrix Services, the main revenue source; Hydrix Medical, which distributes the Implicity AI remote cardiac-monitoring platform in Australia, Singapore and New Zealand; Hydrix Defence, set up during FY26; and Hydrix Ventures, which holds stakes in early-stage companies including Gyder Surgical.
Defence and medical progress
On 5 October 2026 Hydrix said it had delivered a first-stage benchtop integration system to defence contractor NIOA for a kinetic counter-drone payload being developed for the SYPAQ CORVO interceptor under the ASCA Mission SYRACUSE programme. Hydrix is designing the payload's power and interface controller, covering telemetry, safety interlocks and fuzing logic. The announcement did not give a contract value, though the September quarter report refers to a AUD 1.2 million NIOA development contract. The next phase is detailed design, prototype manufacture and flight-test hardware; the Quarterly Report mentions flight trials in the December quarter.
Contract values are not the same as recognised revenue and will be earned over the life of each project.
Financial position
Audited FY26 accounts, released on 30 September 2026, show revenue from customer contracts of AUD 9.74 million, slightly below FY25's AUD 10.09 million, and a loss after tax of AUD 6.72 million, which included a AUD 2.75 million fair-value loss on financial instruments. At 30 June 2026 the group had net liabilities of AUD 8.15 million. Directors referred to material uncertainties over the going-concern basis.
Customer receipts were AUD 2.55 million, which management said were held back by customer capital-raising and milestone timing. The company's formula gives 1.3 quarters of funding, though it says this exceeds two quarters once timing effects are adjusted.
Debt and risks
Most mature on 26 November 2026, with one AUD 1.975 million Loan due in October 2027. Related-party loans are to be converted to Equity subject to AGM approval; if conversions are not approved, the company would need other refinancing. Further risks include dependence on a small number of engineering clients, the time it takes defence prototypes to become production orders, and dilution from Debt conversion.
What to watch
Confirmed items are the AGM on 26 November 2026, the December quarter 4C due in January 2027, and the NIOA flight-trial phase.






Please wait processing your request...